← Back to Search

Behavioural Intervention

Cognitive Screening Tools for Dementia

N/A
Waitlist Available
Research Sponsored by The Cleveland Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up monthly assessment over the study duration (up to 1 year)
Awards & highlights

Summary

This trial will introduce a cognitive risk-calculator and screening tool in eight internal medicine clinics. They will collect data to see how often the tool is used and how it affects the way healthcare providers work.

Who is the study for?
This trial is for primary care settings within the Cleveland Clinic Health System. It's designed to assess how well a new cognitive risk calculator and screening tool work in real-world clinics. The study will look at whether these tools change how doctors manage dementia risks.
What is being tested?
The trial is testing a cognitive risk calculator and an automated screening tool called BACH, aiming to improve early detection of dementia. Clinics are randomly chosen over time to start using these tools, allowing researchers to compare results across different stages.
What are the potential side effects?
Since this trial involves implementing assessment tools rather than medications or medical procedures, traditional physical side effects are not applicable. However, there may be indirect impacts on clinic workflow or patient experience.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~monthly assessment over the study duration (up to 1 year)
This trial's timeline: 3 weeks for screening, Varies for treatment, and monthly assessment over the study duration (up to 1 year) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adoption of RC and BACH: Frequency of BACH Orders
Adoption of RC and BACH: Frequency of Cognitive Screening
Effectiveness of RC and BACH: Frequency of MCI/ADRD, Sleep Disorders, and Depression Diagnoses
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ActiveExperimental Treatment1 Intervention
Active Phase: Implementation of Cognitive Risk Calculator (RC) and Brief Assessment of Cognitive Health (BACH)
Group II: ControlActive Control1 Intervention
Control Phase: Prior to implementation of Cognitive Risk Calculator (RC) and Brief Assessment of Cognitive Health (BACH)

Find a Location

Who is running the clinical trial?

The Cleveland ClinicLead Sponsor
1,045 Previous Clinical Trials
1,370,625 Total Patients Enrolled
1 Trials studying Dementia
200,000 Patients Enrolled for Dementia
National Institute on Aging (NIA)NIH
1,733 Previous Clinical Trials
28,054,953 Total Patients Enrolled
282 Trials studying Dementia
23,629,021 Patients Enrolled for Dementia
~33 spots leftby Aug 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top